Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Alliance for Clinical Trials in Oncology
Related studies linked through entity extraction aliases.
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Status
- RECRUITING
- Phase
- PHASE2
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone
- Status
- TERMINATED
- Phase
- PHASE3
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1